cisplatin

You have access
High Expression of MRE11–RAD50–NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer
BOLAG ALTAN, TAKEHIKO YOKOBORI, MUNENORI IDE, TUYA BAI, TORU YANOMA, AKIHARU KIMURA, NORIMICHI KOGURE, MASAKI SUZUKI, PINJIE BAO, ERITO MOCHIKI, KYOICHI OGATA, TADASHI HANDA, KYOICHI KAIRA, MASAHIKO NISHIYAMA, TAKAYUKI ASAO, TETSUNARI OYAMA and HIROYUKI KUWANO

Anticancer Research October 2016, 36 (10) 5237-5247;
You have access
Safety and Anti-tumor Effects of Docetaxel Plus Cisplatin in Intermediate- and High-risk Endometrial Cancer
DAISUKE MIYAHARA, TAKAHIRO KATSUTA, MIYAKO MAEHARA, YOKO TAKAHASHI, SATOSHI FUKAGAWA, KOUHEI MIYATA, CHIHIRO KIYOSHIMA, FUSANORI YOTSUMOTO, HARUCHIKA ANAN and SHINGO MIYAMOTO

Anticancer Research July 2016, 36 (7) 3725-3729;
You have access
Retrospective Analysis on the Feasibility and Efficacy of Docetaxel–Cisplatin Therapy for Recurrent Endometrial Cancer
TOMOMI NINOMIYA, WATARU YAMAGAMI, NOBUYUKI SUSUMU, TAKESHI MAKABE, KENSUKE SAKAI, MICHIKO WADA, AYA TAKIGAWA, TATSUYUKI CHIYODA, HIROYUKI NOMURA, FUMIO KATAOKA, AKIRA HIRASAWA, KOUJI BANNO and DAISUKE AOKI

Anticancer Research April 2016, 36 (4) 1751-1758;
You have access
Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (≥50 mg/m²) Combination Chemotherapy
YOSHIHIRO YAMAMOTO, KAZUSHI WATANABE, IKUTO TSUKIYAMA, HIROMITSU YABUSHITA, KATSUHIKO MATSUURA and AKIHIKO WAKATSUKI

Anticancer Research April 2016, 36 (4) 1873-1877;
You have access
Early Response of Esophageal Cancer to Neoadjuvant Chemotherapy with Docetaxel–Cisplatin–5-Fluorouracil Represents Sensitivity: A Phase II Study
AKIRA MATSUMOTO, KATSUNORI NISHIKAWA, MASAMI YUDA, YUJIRO TANAKA, YUICHIRO TANISHIMA, YASUHIRO ARAKAWA, YOSHIO ISHIBASHI, TOSHIKAZU SAKUYAMA, NOBUO OMURA, NORIO MITSUMORI, KEISUKE AIBA and KATSUHIKO YANAGA

Anticancer Research April 2016, 36 (4) 1937-1942;
You have access
Effective Treatment for Malignant Pleural Effusion and Ascites with Combined Therapy of Bevacizumab and Cisplatin
LIXIN JIANG, PENG LI, ZHAOHUA GONG, BAOHONG HU, JING MA, JIAHUI WANG, HONGJIN CHU, LIANGMING ZHANG, PING SUN and JIAN CHEN

Anticancer Research March 2016, 36 (3) 1313-1318;
You have access
Neoadjuvant Chemotherapy with Divided-dose Docetaxel, Cisplatin and Fluorouracil for Patients with Squamous Cell Carcinoma of the Esophagus
TOSHIYASU OJIMA, MIKIHITO NAKAMORI, MASAKI NAKAMURA, MASAHIRO KATSUDA, KEIJI HAYATA, TOMOYA KATO, JUNYA KITADANI, HIROTAKA TABATA, AKIHIRO TAKEUCHI, MAKOTO IWAHASHI and HIROKI YAMAUE

Anticancer Research February 2016, 36 (2) 829-834;
You have access
Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study
CLEMENS B. TEMPFER, GÜNTHER A. REZNICZEK, PAULA ENDE, WIEBKE SOLASS and MARC-ANDRÉ REYMOND

Anticancer Research December 2015, 35 (12) 6723-6729;
You have access
Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Nasopharyngeal Carcinoma
MASANORI KOMATSU, YASUHIRO ARAI, KENICHIRO YABUKI, DAISUKE SANO, OSAMU SHIONO, YASUNORI SAKUMA, GOUSHI NISHIMURA, MASAHIRO TAKAHASHI, TAKAHIDE TAGUCHI and NOBUHIKO ORIDATE

Anticancer Research December 2015, 35 (12) 6861-6867;
You have access
Human Mesenchymal Stem Cells Protect Dorsal Root Ganglia from the Neurotoxic Effect of Cisplatin
ARIANNA SCUTERI, MADDALENA RAVASI, MARIANNA MONFRINI, AZZURRA MILANO, GIOVANNA D'AMICO, MARIAROSARIA MILOSO and GIOVANNI TREDICI

Anticancer Research October 2015, 35 (10) 5383-5389;

Main menu

User menu

Search

cisplatin

Pages